Literature DB >> 32681821

Assessing national performance in response to COVID-19.

Dale Fisher1, Yik Ying Teo2, David Nabarro3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32681821      PMCID: PMC7363426          DOI: 10.1016/S0140-6736(20)31601-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   202.731


× No keyword cloud information.
Before the advent of the COVID-19 pandemic, several countries had their preparedness for pandemics assessed via the Global Health Security Index (GHSI). The USA and the UK were identified as two countries most prepared. Experiences with COVID-19 have shown that in-depth assessments of outbreak preparedness need to go beyond publicised plans. Prior assessments of countries such as Vietnam (ranked 50th on the GHSI) and New Zealand (35th on the GHSI) are inconsistent with actual performance. In practice, it is better to benchmark countries during a pandemic in ways that allow information on outcomes and performance to be obtained, analysed, reported, and used in real time. In its April, 2020, COVID-19 Strategy Update WHO recommended that every country implement a comprehensive set of measures to slow down transmission and reduce mortality. Assessment of the performance of COVID-19 response systems in implementing these measures is key to relaxing lockdowns and opening of borders between and within nations. It requires an understanding of public health capacities, government actions, and community behaviours, recognising that people, communities, and nations everywhere are learning to live with COVID-19. Making decisions about border closures or lockdown status without such an assessment gives insufficient attention to the extent to which communities are capable of living with the virus; simply put, actions are taken without some of the essential factors being considered. To try to keep cases of COVID-19 sustained at zero while waiting for a vaccine to become available is a naive option and will result in enormous social and economic harm and isolation for an indefinite period. There are no guarantees that an effective vaccine will be available soon and have high community uptake. The other extreme of accepting uncontrolled transmission leads to excess all-cause mortality and overwhelmed health systems. As people everywhere make sense of the threats posed by COVID-19, they expect decision makers to help them limit both risks to their health and any restrictions on their lifestyles and livelihoods. Trends in the numbers of COVID-19 cases are being used to judge the performance of national responses to COVID-19. But case numbers are unreliable as indicators of the performance of response systems. Serological investigations suggest that case numbers are a small fraction of the total number of people who have been infected. Additionally, the actual numbers of cases recorded are dependent on a country's testing strategy and capacity and the extent to which individuals go for testing. Furthermore, case numbers do not reflect the performance of systems for containing clusters or suppressing virus transmission. These systems, and the potential for their performance to change over time, must be factored into any choices made during the COVID-19 response. Communities want to assess whether the response systems are contributing to the best possible outcomes and expect government decisions to make this happen. The most frequently used outcome measure is the number of COVID-19 deaths. It is hard to conceal fatalities, although methods for counting COVID-19 deaths vary between, and even within, countries. Other outcomes that could be tracked in the future will include long-term COVID-19 sequelae, including pulmonary, cardiac, neurological, and other complications.5, 6 Assessments of national performance must include one or more of these outcome measures obtained consistently over time. Success in reducing deaths or long-term sequelae requires a well organised and resilient hospital system, including emergency departments, general wards, and intensive care units, that is capable of surging in response to increased patient demand. Such a resilient hospital system calls for effective organisation, well trained staff with adequate personal protective equipment, and access to necessary medications, oxygen supplies, and ventilators. These elements are important contributors to systems performance. Performance assessments should also take into account hospital and other health-care providers’ abilities to maintain clinical activities unrelated to the pandemic. Tagging certain medical and surgical procedures, such as routine vaccination and health screening for cancers and other chronic conditions, as elective is incorrect if their postponement will lead to avoidable morbidity and mortality.7, 8 Some disturbance to routine health services is inevitable given that some of the health-care workforce will be assigned to outbreak management. People may be deterred from using routine health services unless they are confident that effective action is being taken to reduce nosocomial infections. Such challenges can be mitigated through the use of telemedicine and the ring-fencing of selected hospitals for non-COVID-19 procedures. Efforts to reduce numbers of COVID-19 cases, deaths, and sequelae require organised capacities within communities that support people as they adapt their lifestyles to live with COVID-19 as a constant threat. Four key capacities are needed. First, communities must have the capacity to detect cases early and interrupt transmission chains. This capacity requires a strong community-based public health system that adjusts its functioning according to locally disaggregated data about the whereabouts of the virus and the effectiveness of the response. All response elements must be locally coordinated and the entire response system must have predictable capacity to surge if needed. Virus testing needs to be easily available and free of charge for all. Useful metrics generated by this capacity include the percentage of positive test results and numbers of tests per million population. The implementation of policies as to who may be tested and the turnaround time for testing can also be quantified. Second, communities need the capacity for isolating individuals with COVID-19 and keeping contacts in quarantine. This function works best if it is implemented rigorously, with people's full cooperation, under public health supervision. Third is the capacity for rapid and thorough tracing of the contacts of cases. Such tracing must also be capable of surging in the face of increased demand. Fourth, public health laws need to be in place, understood, and accepted by the public to reinforce behaviours that are necessary for community wellbeing. In addition to these capacities within communities, income security is crucial to ensure socioeconomic stability and confidence in a national strategy. Many jobs have been, and will be, lost and companies and businesses may be unable to function efficiently due to sickness, isolation, quarantine, and various non-pharmaceutical community interventions including business closure, working from home, and physical distancing.11, 12 Provision of socioeconomic support is needed to remove possible disincentives and facilitate individual and public compliance with COVID-19 response measures. Furthermore, community confidence and compliance are more likely if there is reassurance that supply chains of food and medicines are resilient and that access is maintained for all. Protection and support for vulnerable populations are also crucial. Many outbreaks are occurring in socioeconomically disadvantaged groups—eg, residents of nursing homes, migrant workers, refugees, prisoners, and those living and working in dense settings—that are susceptible to infection and severe disease.13, 14 Such individuals are often poorly paid, work in the informal economy, or on daily wages and may not be able to reduce their risk given the conditions under which they work and live. National governments are responsible for ensuring these groups are protected and supported. Communication and leadership are other important elements of national responses. COVID-19 is a new disease threat and people everywhere expect their leaders to help them make sense of this threat and live with it. They want consistent, honest, and accurate two-way communication. Strategies to communicate are vital and need to use every modality to reach all language and cultural groups and all educational levels of the target community. All leaders need to work together for best results: the virus thrives when decisions are inconsistent or non-transparent. Leadership for the COVID-19 response must be intersectoral and nimble, adapting to new evidence as it emerges. A combination of good leadership and strong public health systems with a fully engaged community can result in well articulated and monitored response capacities. When response systems perform well, they allow for the successful removal of many movement restrictions and the opening of borders between and within countries. An increasing number of societies have modified behaviours and are able to try to function sustainably without lockdowns. People will accept that there will be some COVID-19 cases, and, occasionally, small clusters of cases that can be rapidly controlled. The application of foresight and available evidence relating to transmission means that superspreading events should be rare. We have devised a checklist of capacities for assessing COVID-19 response systems and capacities (panel ). By addressing these seven indicators and quantifying them where possible, we can assess the likelihood of safely removing social restrictions and the opening of borders. Success is the capacity of a country to live with COVID-19. Shutting borders and locking down communities are useful to allow time to develop the response capacity but should not be long-term strategies. The use of criteria such as those outlined here can aid in a local or national self-assessment, especially when deciding whether to restrict movement. These criteria can also help when decisions are made among neighbouring nations about whether to enable people to move between them. Ability to detect and break transmission chains Percentage of cases found by contact tracing Compliance of the community to governmental health directives Testing; percentage positive, capacity per million population, policy, turnaround time Ability to minimise deaths and severe complications Deaths per million population Ventilator capacity per million population Minimise hospital-acquired COVID-19 Personal protective equipment availability Health-care-associated infections Fiscal support for individuals and companies Programmes functioning for those in isolation or quarantine Programmes functioning for those threatened by social restrictions Maintenance of food and medicine supply chains Demonstrable actions in place Protection and support for vulnerable and neglected populations in the community Recent clusters in vulnerable groups Demonstrable actions in place Maintenance of usual health services Essential services are never reduced Non-essential services are restored promptly This online publication has been corrected. The corrected version first appeared at thelancet.com on July 17, 2020
  11 in total

1.  Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.

Authors:  Fiona P Havers; Carrie Reed; Travis Lim; Joel M Montgomery; John D Klena; Aron J Hall; Alicia M Fry; Deborah L Cannon; Cheng-Feng Chiang; Aridth Gibbons; Inna Krapiunaya; Maria Morales-Betoulle; Katherine Roguski; Mohammad Ata Ur Rasheed; Brandi Freeman; Sandra Lester; Lisa Mills; Darin S Carroll; S Michele Owen; Jeffrey A Johnson; Vera Semenova; Carina Blackmore; Debra Blog; Shua J Chai; Angela Dunn; Julie Hand; Seema Jain; Scott Lindquist; Ruth Lynfield; Scott Pritchard; Theresa Sokol; Lynn Sosa; George Turabelidze; Sharon M Watkins; John Wiesman; Randall W Williams; Stephanie Yendell; Jarad Schiffer; Natalie J Thornburg
Journal:  JAMA Intern Med       Date:  2020-07-21       Impact factor: 21.873

2.  Health equity and COVID-19: global perspectives.

Authors:  Efrat Shadmi; Yingyao Chen; Inês Dourado; Inbal Faran-Perach; John Furler; Peter Hangoma; Piya Hanvoravongchai; Claudia Obando; Varduhi Petrosyan; Krishna D Rao; Ana Lorena Ruano; Leiyu Shi; Luis Eugenio de Souza; Sivan Spitzer-Shohat; Elizabeth Sturgiss; Rapeepong Suphanchaimat; Manuela Villar Uribe; Sara Willems
Journal:  Int J Equity Health       Date:  2020-06-26

Review 3.  COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors.

Authors:  Raul D Mitrani; Nitika Dabas; Jeffrey J Goldberger
Journal:  Heart Rhythm       Date:  2020-06-26       Impact factor: 6.343

4.  Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicenters.

Authors:  H Lau; T Khosrawipour; P Kocbach; H Ichii; J Bania; V Khosrawipour
Journal:  Pulmonology       Date:  2020-06-06

5.  Income security during public health emergencies: the COVID-19 poverty trap in Vietnam.

Authors:  Phuong Bich Tran; Gunnel Hensing; Tom Wingfield; Salla Atkins; Kristi Sidney Annerstedt; Joseph Kazibwe; Ewan Tomeny; Olivia Biermann; Jennifer Thorpe; Rachel Forse; Knut Lönnroth
Journal:  BMJ Glob Health       Date:  2020-06

6.  COVID-19 will not leave behind refugees and migrants.

Authors: 
Journal:  Lancet       Date:  2020-04-04       Impact factor: 79.321

7.  Estimates of the ongoing need for social distancing and control measures post-"lockdown" from trajectories of COVID-19 cases and mortality.

Authors:  Mike Lonergan; James D Chalmers
Journal:  Eur Respir J       Date:  2020-07-23       Impact factor: 16.671

Review 8.  Income security during periods of ill health: a scoping review of policies, practice and coverage in low-income and middle-income countries.

Authors:  Jennifer Thorpe; Kerri Viney; Gunnel Hensing; Knut Lönnroth
Journal:  BMJ Glob Health       Date:  2020-06

9.  The need to improve the laws and regulations relevant to the outbreak of COVID-19: What might be learned from China?

Authors:  Hao Li; Mengnan Hu; Shuang Liu
Journal:  J Glob Health       Date:  2020-06       Impact factor: 4.413

10.  Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.

Authors:  Peter J Mazzone; Michael K Gould; Douglas A Arenberg; Alexander C Chen; Humberto K Choi; Frank C Detterbeck; Farhood Farjah; Kwun M Fong; Jonathan M Iaccarino; Samuel M Janes; Jeffrey P Kanne; Ella A Kazerooni; Heber MacMahon; David P Naidich; Charles A Powell; Suhail Raoof; M Patricia Rivera; Nichole T Tanner; Lynn K Tanoue; Alain Tremblay; Anil Vachani; Charles S White; Renda Soylemez Wiener; Gerard A Silvestri
Journal:  Chest       Date:  2020-04-23       Impact factor: 9.410

View more
  11 in total

1.  A Country Pandemic Risk Exposure Measurement Model.

Authors:  Simon Grima; Murat Kizilkaya; Ramona Rupeika-Apoga; Inna Romānova; Rebecca Dalli Gonzi; Mihajlo Jakovljevic
Journal:  Risk Manag Healthc Policy       Date:  2020-10-09

2.  Innovations, contestations and fragilities of the health system response to COVID-19 in the Gauteng Province of South Africa.

Authors:  Laetitia C Rispel; Carol Marshall; Busisiwe Matiwane; Immaculate Sabelile Tenza
Journal:  PLoS One       Date:  2021-12-17       Impact factor: 3.240

3.  Impact of COVID-19 Pandemic on the Outcomes in Patients With Critical Limb Threatening Ischaemia and Diabetic Foot Infection.

Authors:  Hany Zayed; Mustafa Musajee; Narayanan Thulasidasan; Mohamed Sayed; Federica Francia; Meryl Green; Martin Arissol; Alpa Lakhani; Lukla Biasi; Sanjay Patel
Journal:  Ann Surg       Date:  2020-12-22       Impact factor: 13.787

4.  What matters the most in curbing early COVID-19 mortality? A cross-country necessary condition analysis.

Authors:  Bo Yan; Yao Liu; Bin Chen; Xiaomin Zhang; Long Wu
Journal:  Public Adm       Date:  2022-07-17

5.  Patient-safety incidents during COVID-19 health crisis in France: An exploratory sequential multi-method study in primary care.

Authors:  Jean-Pascal Fournier; Jean-Baptiste Amélineau; Sandrine Hild; Jérôme Nguyen-Soenen; Anaïs Daviot; Benoit Simonneau; Paul Bowie; Liam Donaldson; Andrew Carson-Stevens
Journal:  Eur J Gen Pract       Date:  2021-12       Impact factor: 1.904

6.  Perception of COVID-19 Vaccination Amongst Physicians in Colombia.

Authors:  Jorge L Alvarado-Socarras; Andrea Liliana Vesga-Varela; Doris Cristina Quintero-Lesmes; Marcela M Fama-Pereira; Norma C Serrano-Diaz; Mauricio Vasco; Virgil Carballo-Zarate; Lysien I Zambrano; Alberto Paniz-Mondolfi; Alfonso J Rodriguez-Morales
Journal:  Vaccines (Basel)       Date:  2021-03-19

Review 7.  Exploring the actionability of healthcare performance indicators for quality of care: a qualitative analysis of the literature, expert opinion and user experience.

Authors:  Erica Barbazza; Niek S Klazinga; Dionne S Kringos
Journal:  BMJ Qual Saf       Date:  2021-05-07       Impact factor: 7.035

8.  Are overwhelmed health systems an inevitable consequence of covid-19? Experiences from China, Thailand, and New York State.

Authors:  Viroj Tangcharoensathien; Mary T Bassett; Qingyue Meng; Anne Mills
Journal:  BMJ       Date:  2021-01-22

9.  Impact of COVID-19 Pandemic Declaration on New Oncology Trial Commencements: An Interrupted Time Series with Segmented Regression Analysis.

Authors:  Hyeon Uk Bin; Sohyun Jeong; Heeyoung Lee
Journal:  Healthcare (Basel)       Date:  2022-03-07

Review 10.  Macro level influences on strategic responses to the COVID-19 pandemic - an international survey and tool for national assessments.

Authors:  Raheelah Ahmad; Rifat A Atun; Gabriel Birgand; Enrique Castro-Sánchez; Esmita Charani; Ewan B Ferlie; Izhar Hussain; Andrew Kambugu; Jaime Labarca; Gabriel Levy Hara; Martin McKee; Marc Mendelson; Sanjeev Singh; Jay Varma; Nina J Zhu; Walter Zingg; Alison H Holmes
Journal:  J Glob Health       Date:  2021-07-01       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.